Atara Biotherapeutics Inc. (ATRA) Income Statement Analysis - Revenue, Earnings & Profitability Metrics - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    Atara Biotherapeutics Inc...

    NASDAQ: ATRA · Real-Time Price · USD
    12.18
    -0.73 (-5.65%)
    At close: Sep 08, 2025, 3:59 PM
    12.69
    4.19%
    After-hours: Sep 08, 2025, 05:55 PM EDT

    Atara Biotherapeutics Income Statement

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
    Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
    Revenue
    		 128.94M 8.57M 63.57M 20.34M
    Cost of Revenue
    		 21.01M 8.89M 14.57M 11.38M
    Gross Profit
    		 107.93M -313K 49.01M 8.96M
    Operating Income
    		 -83.44M -276.01M -280.51M -340.46M
    Interest Income
    		 2.11M 5.43M 3.06M 367K
    Pretax Income
    		 -85.42M -276.11M -228.29M -340.1M
    Net Income
    		 -85.4M -276.13M -2.28B -3.4B
    Selling & General & Admin
    		 39.89M 49.8M 71.55M 78.8M
    Research & Development
    		 151.48M 224.78M 272.53M 282M
    Other Expenses
    		 n/a n/a -700K n/a
    Operating Expenses
    		 191.37M 275.69M 344.09M 360.8M
    Interest Expense
    		 4.62M 5.29M 373K n/a
    Selling & Marketing Expenses
    		 n/a -1.11M n/a n/a
    Cost & Expenses
    		 212.38M 284.58M 344.09M 360.8M
    Income Tax Expense
    		 -12K 15K 12K 46K
    Shares Outstanding (Basic)
    		 7.49M 4.24M 4.08M 3.75M
    Shares Outstanding (Diluted)
    		 7.49M 4.24M 4.08M 3.75M
    EPS (Basic)
    		 -11.41 -65.18 -55.96 -90.78
    EPS (Diluted)
    		 -11.41 -65.18 -55.96 -90.78
    EBITDA
    		 -75.75M -266M -213.72M -331.12M
    EBIT
    		 -80.8M -270.83M -228.29M -340.46M
    Depreciation & Amortization
    		 5.05M 4.83M 14.57M 11.38M

    Add to Watchlist